| Autor: |
Davis JL; School of Biosciences, University of Sheffield, Sheffield, UK., Norwood JS; School of Biosciences, University of Sheffield, Sheffield, UK., Smith RE; School of Biosciences, University of Sheffield, Sheffield, UK., O'Dea F; School of Biosciences, University of Sheffield, Sheffield, UK., Chellappa K; School of Biosciences, University of Sheffield, Sheffield, UK., Rowe ML; School of Biosciences, University of Sheffield, Sheffield, UK., Williamson MP; School of Biosciences, University of Sheffield, Sheffield, UK., Stafford GP; School of Clinical Dentistry, University of Sheffield, Sheffield, UK., Vinogradov E; Vaccine and Emerging Infections Research, Human Health Therapeutics Research Centre, National Research Council, Ottawa, Canada., Maes E; University of Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41, UAR 2014, PLBS, Lille, France., Guérardel Y; UMR 8576, UGSF, Unité de Glycobiologie Structurale et Fonctionnelle, CNRS, Université de Lille, Lille, France; Institute for GlycO-Core Research (iGCORE), Gifu University, Gifu, Japan., Mesnage S; School of Biosciences, University of Sheffield, Sheffield, UK. Electronic address: s.mesnage@sheffield.ac.uk. |
Full Text from ScienceDirect